The field of targeted nuclear medicine is rapidly evolving as new players and innovative therapies enter the space. Two Lu-177 targeted radiotherapies are currently marketed from Novartis, for Prostate Cancer
The field of targeted nuclear medicine is rapidly evolving as new players and innovative therapies enter the space. Two Lu-177 targeted radiotherapies are currently marketed from Novartis, for Prostate Cancer
“Supply Chain Logistics For A PET Radiotracer Manufacture”
Supply chain for an 18F radioisotope based PET radiotracer manufacture is discussed in detail along with brief manufacturing descriptions provided for context. A critical report for supply chain, manufacturing, business and investing personnel to familiarize with the basics of supply chain for this category of high application, commercially critical PET diagnostic imaging agents.
Click the icon below to download the eReport.
